Related Experiment Video
Updated: Oct 1, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
[Congenital hypopituitarism and giant cell hepatitis in a three month old girl]
E E Reiterer1, W Zenz, J Deutsch
1Universitätsklinik für Kinder- und Jugendheilkunde Graz, Osterreich, Germany. ElkeReiterer@kfunigraz.ac.at
Insights
Neonatal hypopituitarism can present with hypoglycemia and liver disease. Hormone replacement therapy improved the condition, showing a good prognosis for both infant and liver issues.
Area of Science:
- Pediatric Endocrinology
- Neonatal Medicine
- Hepatology
Background:
- Neonatal hypopituitarism is a rare condition affecting hormone production.
- Liver dysfunction, including cholestasis, can be associated with hypopituitarism.
- Early diagnosis and intervention are crucial for managing infant health outcomes.
Observation:
- A case of a three-month-old girl with recurrent hypoglycemia and neonatal cholestasis is presented.
- Metabolic disorders were ruled out; liver biopsy showed giant cell hepatitis and bile duct hypoplasia.
- Low levels of ACTH, Cortisol, and growth hormone (hGH) were observed during hypoglycemic episodes, alongside an "empty sella" on brain MRI.
Findings:
- Hormone replacement therapy with hydrocortisone, growth hormone, and thyroxine resolved hypoglycemia.
- Biochemical markers of liver function, including transaminases and bilirubin, normalized with treatment.
- The patient exhibited normal growth and development post-treatment.
Implications:
- Hypoglycemia is a key early indicator of neonatal hypopituitarism in infants.
- The link between liver disease and hypopituitarism, though rarely reported, highlights the need for comprehensive endocrine evaluation.
- Effective hormone replacement therapy offers a positive prognosis for both neonatal hypopituitarism and associated liver dysfunction.
Case Report:
A three month old girl, with recurrent hypoglycemia and neonatal cholestasis, is reported. A metabolic disease could be excluded. The liver biopsy revealed giant cell hepatitis and intrahepatic bile duct hypoplasia. ACTH, Cortisol and hGH measured during hypoglycemia were low. Magnetic tomography (MR) of the brain showed an "empty sella". After beginning a replacement therapy with hydrocortisone, growth hormone and thyroxine there was no further episode of hypoglycemia. Transaminases and bilirubin levels normalized. The girl is in good condition, growth and development are normal.
Discussion:
Hypoglycemia is often the first sign in childrens with neonatal hypopituitarism. The association of liver disease and hypopituitarism has been documented in a few reports. The pathophysiological mechanism leading to the liver dysfunction is not well understood. The prognosis of neonatal hypopituitarism as well as the concomitant liver disease is good under sufficient replacement therapy.
Related Concept Videos
Goiter
Hypothyroidism II: Pathophysiology
Cytomegalovirus Disease
Encephalitis l: Introduction
Cushing Syndrome II: Pathophysiology
Hepatitis